Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH (CSDH)
Primary Purpose
Conscious Sedation
Status
Completed
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Magnesium sulphate
Fentanyl
Propofol
Sponsored by
About this trial
This is an interventional treatment trial for Conscious Sedation focused on measuring Magnesium sulphate, Fentanyl, Conscious sedation, chronic subdural haematoma, Propofol, Burr hole
Eligibility Criteria
Inclusion Criteria:
- age > 50 years
- ASA (American Society of Anesthesiologists physical status) grade I to II
- Glasgow coma scale 14-15
- Unilateral chronic subdural hematoma
Exclusion Criteria:
- Hypertension (diastolic blood pressure > 160 mmHg)
- Bradycardia (<50 bpm)
- Ischemic heart disease (<6 months)
- Second- or third-degree heart block
- Long-term abuse of or addiction to alcohol, tobacco, opioids, and sedative-hypnotic drugs (>6 months)
- Allergy to study drugs
- Neuropsychiatric diseases
- Predicted difficult airway according to Ganzouri score >4.
- Patients with deviation in the surgical technique or with inadequacy of local anesthesia were excluded from the study.
Sites / Locations
- Kasr El Aini Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Magnesium (M) group
Fentanyl (F) group
Arm Description
Magnesium (M) group (n=17) , in which magnesium sulphate is given as adjuvant to propofol for sedation
Fentanyl (F) group (n=17), in which fentanyl is given as adjuvant to propofol for sedation
Outcomes
Primary Outcome Measures
Total amount of Propofol consumption in each group
To measure total amount of propofol consumption from induction of conscious sedation till the end of the operation and to compare it between both groups
Secondary Outcome Measures
To measure the total number of intraoperative patient's movements
Intraoperative patient's movement is defined as those likely to interfere with surgical procedure such as bending of hand and/or leg and movement of head
Heart rate
Heart rate in beats/min
Non invasive blood pressure
Systolic and diastolic blood pressure in mmhg
To assess surgeon satisfaction score
Surgeon satisfaction was assessed as follows: 1, extremely dissatisfied; 2, not satisfied but able to manage; 3, satisfied; 4, extremely satisfied.
VAS score for pain
The pain VAS is a unidimensional measure of pain intensity, the score is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale])
Time to first rescue analgesic
The time when the patient first requires analgesia.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03548493
Brief Title
Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH
Acronym
CSDH
Official Title
Magnesium Sulphate Versus Fentanyl as Adjuvants to Propofol Xylocaine Combination for Conscious Sedation During Chronic Subdural Haematoma Surgery. Comparative Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
April 10, 2018 (Actual)
Primary Completion Date
August 8, 2018 (Actual)
Study Completion Date
August 9, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kasr El Aini Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators hypothesize that magnesium sulphate owing to its analgesic and sedative properties is not inferior to fentanyl in providing conscious sedation as adjuvants to propofol and local injection of lidocaine in patients undergoing surgery for evacuation of subdural haematoma. Consequently, the investigators are testing this hypothesis by comparing the sedative and analgesic effects of magnesium sulphate versus fentanyl as adjuvants to propofol lidocaine admixture for conscious sedation in patients undergoing burr hole surgery for evacuation of subdural haematoma.
Detailed Description
Following institutional ethical committee approval, 34 patients undergoing burr-hole surgery for chronic subdural hemorrhage were included in this prospective, randomized, double-blind study.
Written informed consent were obtained from all subjects before enrollment in the study.
During the preanesthetic checkup,the operative procedure and anesthetic techniques were explained to all patients.
Upon arrival to operating theater, standard monitoring were applied to all patients and bispectral index was applied before starting the drug infusions and was used for maintenance of sedation during operation.
Subjects were randomized into 2 groups. Magnesium (M) group received Magnesium sulphate 50mg/kg IV over 15 minutes Followed by continuous infusion at 15 mg/kg/h Fentanyl (F) group received fentanyl 1 μg /kg IV bolus over 15 minutes Followed by continuous infusion starting at 0.5 μg /kg/h Loading and infusion doses of magnesium sulphate and loading doses of fentanyl were chosen from previous studies.
In both groups fentanyl and magnesium sulphate were accompanied by IV propofol at a dose of 50- 150 μg /kg/min bolus over 10 minutes to achieve target sedation level, that is, Ramsay sedation scale (RSS) 3, if RSS afterwards does not reach 3, a supplementary bolus dose of 0.2 mg/kg propofol were given to the patients, followed by ( 20-40 μg /kg/ min) to maintain Intraoperative level of sedation by bispectral index (BIS ) reading by 60-80 After achieving predefined target sedation level (RSS of 3), surgeons infiltrated the sites of the burrholes with 20 mL of a local anesthetic solution containing 10 mL of 0.5% bupivacaine and 10 mL of 2% lidocaine with adrenaline infiltrated locally at least 5 minutes before surgical incision. After burr-hole craniotomy followed by the hematoma evacuation is accomplished, the Infusion of sedatives were discontinued just after placement of the final skin suture.
Intraoperative patient's movement is defined as those likely to interfere with surgical procedure such as bending of hand and/or leg and movement of head were recorded. The first intervention is to attempt patient reassurance for 30 seconds. If movement continues then the bolus dose of propofol of 0.5 mg/kg was given and infusion dose was increased in the previously described manner till the maximum dose to regain BIS sedation score between 60-80.
If the patient starts to move again the same sequence was repeated. Induction of general anesthesia was deemed the final intervention in case satisfactory condition was not achieved within the rescue propofol.
All patients were transferred to the post-anesthesia care unit (PACU) after surgery.
The data collected are:
Total amount of Propofol consumption.
Total number of patient movements
The intraoperative and postoperative hemodynamic data
VAS (Visual analogue scale for pain) score
Time to first rescue analgesic
Adverse events
Surgeon satisfaction score was recorded.
Statistical analysis:
Data was analyzed using SPSS © Statistics version 23 (IBM© Corp., Armonk, NY, USA). Chi-square test (Fisher's exact test) was used to examine the relation between qualitative variables. For quantitative data, comparison between the two groups was done using independent sample t-test or Mann-Whitney test as appropriate. All tests were two-tailed. A p-value < 0.05 was considered significant.
Sample Size calculation:
A previous study reported that pre-procedure magnesium sulphate reduced the total propofol requirements to 130±19.09 mg compared to 172.8±29.09 mg with pre-procedure fentanyl. Based on these results, a sample size of 15 cases in each group was satisfactory to elicit the difference at an alpha level of 0.05 and a power of the test of 95%. The sample size was increased to 17 per group to compensate for possible dropouts.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Conscious Sedation
Keywords
Magnesium sulphate, Fentanyl, Conscious sedation, chronic subdural haematoma, Propofol, Burr hole
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
34 patients are randomly divided by computer designed lists and then concealed in closed envelopes into 2 equal groups:
Group A (n=17) will receive magnesium sulphate adjuvant to propofol for sedation.
Group B (n=17) will receive fentanyl adjuvant to propofol for sedation
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Magnesium (M) group
Arm Type
Experimental
Arm Description
Magnesium (M) group (n=17) , in which magnesium sulphate is given as adjuvant to propofol for sedation
Arm Title
Fentanyl (F) group
Arm Type
Active Comparator
Arm Description
Fentanyl (F) group (n=17), in which fentanyl is given as adjuvant to propofol for sedation
Intervention Type
Drug
Intervention Name(s)
Magnesium sulphate
Intervention Description
Magnesium sulphate will be given to the experimental group in a dose of 50mg/kg IV over 15 minutes followed by continuous infusion at 15 mg/kg/h
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
Fentanyl will be given to the active comparator group in a dose of 1 μg /kg IV bolus over 15 minutes followed by continuous infusion starting at 0.5 μg /kg/h
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
In both groups Fentanyl and magnesium sulphate will be accompanied by IV propofol at a dose of 50- 150 μg /kg) bolus over 15 minutes to achieve target sedation level, that is Ramsay sedation scale (RSS) 3,if RSS afterwards does not reach 3, a supplementary bolus dose of 0.2 mg/kg propofol will be given to the patients, followed by ( 20-40 μg /kg/ min) to maintain Intraoperative level of sedation by bispectral index (BIS ) reading by 60-80%
Primary Outcome Measure Information:
Title
Total amount of Propofol consumption in each group
Description
To measure total amount of propofol consumption from induction of conscious sedation till the end of the operation and to compare it between both groups
Time Frame
From the start of propofol infusion after arrival to the operating room and throughout the duration of the surgery
Secondary Outcome Measure Information:
Title
To measure the total number of intraoperative patient's movements
Description
Intraoperative patient's movement is defined as those likely to interfere with surgical procedure such as bending of hand and/or leg and movement of head
Time Frame
From the start of the surgery and throughout the duration of the surgery
Title
Heart rate
Description
Heart rate in beats/min
Time Frame
Arrival at the operating room, after bolus administration of drug, at skin incision, at 1,2,5,10,15 min and 10 min after skin incision, every 15 minutes intraoperative, on arrival, 5,10,15,30 min and 1 hour at the PACU
Title
Non invasive blood pressure
Description
Systolic and diastolic blood pressure in mmhg
Time Frame
Arrival at the operating room, after bolus administration of drug, at skin incision, at 1,2,5,10,15 min and 10 min after skin incision, every 15 minutes intraoperative, on arrival, 5,10,15,30 min and 1 hour at the PACU
Title
To assess surgeon satisfaction score
Description
Surgeon satisfaction was assessed as follows: 1, extremely dissatisfied; 2, not satisfied but able to manage; 3, satisfied; 4, extremely satisfied.
Time Frame
30 minutes after the end of the surgery
Title
VAS score for pain
Description
The pain VAS is a unidimensional measure of pain intensity, the score is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale])
Time Frame
at skin closure and at 1hr, 2 hrs. 3hrs and 6 hrs. after PACU admission.
Title
Time to first rescue analgesic
Description
The time when the patient first requires analgesia.
Time Frame
During the first 24 hours in the postoperative period
10. Eligibility
Sex
All
Minimum Age & Unit of Time
51 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age > 50 years
ASA (American Society of Anesthesiologists physical status) grade I to II
Glasgow coma scale 14-15
Unilateral chronic subdural hematoma
Exclusion Criteria:
Hypertension (diastolic blood pressure > 160 mmHg)
Bradycardia (<50 bpm)
Ischemic heart disease (<6 months)
Second- or third-degree heart block
Long-term abuse of or addiction to alcohol, tobacco, opioids, and sedative-hypnotic drugs (>6 months)
Allergy to study drugs
Neuropsychiatric diseases
Predicted difficult airway according to Ganzouri score >4.
Patients with deviation in the surgical technique or with inadequacy of local anesthesia were excluded from the study.
Facility Information:
Facility Name
Kasr El Aini Hospital
City
Cairo
ZIP/Postal Code
11562
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
18642135
Citation
Guzel A, Kaya S, Ozkan U, Ufuk Aluclu M, Ceviz A, Belen D. Surgical treatment of chronic subdural haematoma under monitored anaesthesia care. Swiss Med Wkly. 2008 Jul 12;138(27-28):398-403. doi: 10.4414/smw.2008.12121.
Results Reference
background
PubMed Identifier
26018670
Citation
Bishnoi V, Kumar B, Bhagat H, Salunke P, Bishnoi S. Comparison of Dexmedetomidine Versus Midazolam-Fentanyl Combination for Monitored Anesthesia Care During Burr-Hole Surgery for Chronic Subdural Hematoma. J Neurosurg Anesthesiol. 2016 Apr;28(2):141-6. doi: 10.1097/ANA.0000000000000194.
Results Reference
background
PubMed Identifier
26661141
Citation
Sato M, Shirakami G, Fukuda K. Comparison of general anesthesia and monitored anesthesia care in patients undergoing breast cancer surgery using a combination of ultrasound-guided thoracic paravertebral block and local infiltration anesthesia: a retrospective study. J Anesth. 2016 Apr;30(2):244-51. doi: 10.1007/s00540-015-2111-z. Epub 2015 Dec 10.
Results Reference
background
PubMed Identifier
21806629
Citation
Drown MB. Integrative review utilizing dexmedetomidine as an anesthetic for monitored anesthesia care and regional anesthesia. Nurs Forum. 2011 Jul-Sep;46(3):186-94. doi: 10.1111/j.1744-6198.2011.00229.x.
Results Reference
background
PubMed Identifier
21256626
Citation
David H, Shipp J. A randomized controlled trial of ketamine/propofol versus propofol alone for emergency department procedural sedation. Ann Emerg Med. 2011 May;57(5):435-41. doi: 10.1016/j.annemergmed.2010.11.025. Epub 2011 Jan 21.
Results Reference
background
PubMed Identifier
27857689
Citation
Wang W, Feng L, Bai F, Zhang Z, Zhao Y, Ren C. The Safety and Efficacy of Dexmedetomidine vs. Sufentanil in Monitored Anesthesia Care during Burr-Hole Surgery for Chronic Subdural Hematoma: A Retrospective Clinical Trial. Front Pharmacol. 2016 Nov 3;7:410. doi: 10.3389/fphar.2016.00410. eCollection 2016.
Results Reference
background
PubMed Identifier
19378524
Citation
Lauretti GR. Mechanisms of analgesia of intravenous lidocaine. Rev Bras Anestesiol. 2008 May-Jun;58(3):280-6. doi: 10.1590/s0034-70942008000300011. English, Portuguese.
Results Reference
background
PubMed Identifier
17437152
Citation
Cizmeci P, Ozkose Z. Magnesium sulphate as an adjuvant to total intravenous anesthesia in septorhinoplasty: a randomized controlled study. Aesthetic Plast Surg. 2007 Mar-Apr;31(2):167-73. doi: 10.1007/s00266-006-0194-5.
Results Reference
background
PubMed Identifier
28424537
Citation
Prontera A, Baroni S, Marudi A, Valzania F, Feletti A, Benuzzi F, Bertellini E, Pavesi G. Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil. Drug Des Devel Ther. 2017 Mar 3;11:593-598. doi: 10.2147/DDDT.S124736. eCollection 2017.
Results Reference
background
Learn more about this trial
Magnesium Sulphate Versus Fentanyl for Conscious Sedation in CSDH
We'll reach out to this number within 24 hrs